Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and added 'MedlinePlus Genetics' as a related topic on the study page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe new screenshot shows removal of the 'Multiple myeloma' item from related topics and the 'MedlinePlus Genetics' entry in related topics.SummaryDifference0.3%

- Check25 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma; this reduces coverage of a notable medical condition in the genetics section.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded a MedlinePlus Genetics topic covering Multiple myeloma, expanding core content and proper noun coverage.SummaryDifference0.1%

- Check40 days agoChange DetectedUpdates include a government-funding notice and a new v3.2.0 revision, with removal of a MedlinePlus Genetics topic (Multiple myeloma) and the old v3.1.0 tag.SummaryDifference1%

- Check47 days agoChange DetectedCore terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' with a version bump to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.